This topic contains a solution. Click here to go to the answer

Author Question: PKU, Tay-Sachs disease, and galactosemia have in common the fact that they are all A) forms of ... (Read 35 times)

bobypop

  • Hero Member
  • *****
  • Posts: 539
PKU, Tay-Sachs disease, and galactosemia have in common the fact that they are all
 
  A) forms of mental retardation produced by poor maternal diet during pregnancy.
  B) the results of hormonal deficiencies prenatally or during infancy.
  C) accompanied by sudden decreases in IQ during adolescence.
  D) genetically-based disorders accompanied by low intelligence.

Question 2

In which case did the judge decide that the WISC, WISC-R, and Stanford-Binet tests, when
  used in conjunction with the statutorially-mandated other criteria for determining an
  appropriate educational program for a child do not discriminate against
 
  Black children?
  A) Georgia NAACP vs. State of Georgia
  B) Larry P. vs. Riles
  C) Hobson vs. Hansen
  D) PASE vs. Hannon
  E) Diana vs. State Board of Education



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

k.lashomb

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

D

Answer to Question 2

D




bobypop

  • Member
  • Posts: 539
Reply 2 on: Jun 19, 2018
Excellent


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library